Positron emitting magnetic nanoconstructs for PET/MR imaging.

Hybrid PET/MRI scanners have the potential to provide fundamental molecular, cellular, and anatomic information essential for optimizing therapeutic and surgical interventions. However, their full utilization is currently limited by the lack of truly multi-modal contrast agents capable of exploiting the strengths of each modality. Here, we report on the development of long-circulating positron-emitting magnetic nanoconstructs (PEM) designed to image solid tumors for combined PET/MRI. PEMs are synthesized by a modified nano-precipitation method mixing poly(lactic-co-glycolic acid) (PLGA), lipids, and polyethylene glycol (PEG) chains with 5 nm iron oxide nanoparticles (USPIOs). PEM lipids are coupled with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and subsequently chelated to (64)Cu. PEMs show a diameter of 140 ± 7 nm and a transversal relaxivity r2 of 265.0 ± 10.0 (mM × s)(-1), with a r2/r1 ratio of 123. Using a murine xenograft model bearing human breast cancer cell line (MDA-MB-231), intravenously administered PEMs progressively accumulate in tumors reaching a maximum of 3.5 ± 0.25% ID/g tumor at 20 h post-injection. Correlation of PET and MRI signals revealed non-uniform intratumoral distribution of PEMs with focal areas of accumulation at the tumor periphery. These long-circulating PEMs with high transversal relaxivity and tumor accumulation may allow for detailed interrogation over multiple scales in a clinically relevant setting.

[1]  Taeghwan Hyeon,et al.  Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. , 2009, Chemical Society reviews.

[2]  J. Bulte,et al.  Instant MR labeling of stem cells using magnetoelectroporation , 2005, Magnetic resonance in medicine.

[3]  P. Walczak,et al.  Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: The case of the Shiverer dysmyelinated mouse brain , 2007, Magnetic resonance in medicine.

[4]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[5]  Ji Guo,et al.  Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[6]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[7]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[8]  Samuel A Wickline,et al.  Nanotechnology for molecular imaging and targeted therapy. , 2003, Circulation.

[9]  David A. Mankoff,et al.  Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol , 2008, Journal of Nuclear Medicine.

[10]  Nicholas J Long,et al.  'Two is better than one'--probes for dual-modality molecular imaging. , 2009, Chemical communications.

[11]  Jaehong Key,et al.  Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging. , 2013, Biomaterials.

[12]  Jun Wang,et al.  Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Liangfang Zhang,et al.  Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. , 2011, Molecular pharmaceutics.

[14]  Enzo Terreno,et al.  Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.

[15]  Ralph Weissleder,et al.  Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. , 2011, Accounts of chemical research.

[16]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[17]  J. Bulte,et al.  Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[18]  R. Jain,et al.  Extravascular transport in normal and tumor tissues. , 1986, Critical reviews in oncology/hematology.

[19]  Bernd J Pichler,et al.  Latest Advances in Molecular Imaging Instrumentation , 2008, Journal of Nuclear Medicine.

[20]  M. Neeman,et al.  MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation , 2013, NMR in biomedicine.

[21]  Jason S. Lewis,et al.  Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System , 2011, Journal of Nuclear Medicine.

[22]  P. Decuzzi,et al.  Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging. , 2013, Biomaterials.

[23]  C. Reutelingsperger,et al.  Molecular Imaging to Identify the Vulnerable Plaque—From Basic Research to Clinical Practice , 2012, Molecular Imaging and Biology.

[24]  R. Weissleder,et al.  Molecular imaging in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[25]  Z. Fayad,et al.  Molecular Imaging in Atherosclerosis: FDG PET , 2012, Current Atherosclerosis Reports.

[26]  D. Mankoff,et al.  Advances in molecular imaging for breast cancer detection and characterization , 2012, Breast Cancer Research.

[27]  Michael J. Welch,et al.  In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.

[28]  Jinwoo Cheon,et al.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. , 2008, Angewandte Chemie.

[29]  Mauro Ferrari,et al.  Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast , 2010, Nature nanotechnology.

[30]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[31]  Jesse V Jokerst,et al.  Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.

[32]  P. Decuzzi,et al.  Design Maps for the Hyperthermic Treatment of Tumors with Superparamagnetic Nanoparticles , 2013, PloS one.

[33]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[34]  F. Epstein,et al.  Multimodality cardiovascular molecular imaging, part I. , 2008, Circulation. Cardiovascular imaging.

[35]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[36]  Jinwoo Cheon,et al.  Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.

[37]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Sanjiv S Gambhir,et al.  microPET-Based Biodistribution of Quantum Dots in Living Mice , 2007, Journal of Nuclear Medicine.

[39]  Yeong Su Ha,et al.  Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. , 2010, Small.